study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
Published 5 years ago • 2.2K plays • Length 4:14Download video MP4
Download video MP3
Similar videos
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
2:25
what is her2-positive breast cancer? | dana-farber cancer institute
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
2:46
program for patients with breast cancer brain metastases | dana-farber cancer institute
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
2:00
survival advantage observed in her2 breast cancer with brain metastasis
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
39:15
metastatic breast cancer forum 2018: clinical trials 101 | dana-farber cancer institute
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
1:21
esmo24: nancy lin, md metastatic brain cancer | dana-farber cancer institute
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
1:49
sabcs22: sara tolaney, md, mph | dana-farber cancer institute